HelixoMetry, Inc. is a privately held, Silicon Valley based Intellectual Capital Portfolio

* FRACTOGENE PATENT PENDING *

Founder's Page
Founder of Helixometry
cob@helixometry.com
tel: (408) 891-7187

Aug 1, 2002
FractoGene Patent Pending. Initial offerings outlined, first in a closely held manner.

FractoGene of HelixoMetry is marketed in 7 overlapping Business Models

"Seven Sisters":

(1) Translation Memory Company, Partnership / M/A

(2) "Big Pharma" Pharmaceutical Company, M/A

(3) "Big IT" Information Technology Company, Acquisition

(4) Bioinformatics Company Cooperation / Partnership

(5) Genomics Data-Base Company, M/A / Partnership

Advantage: Boosting business from exon search to exon AND intron repetition search. Fastest path for cash-flow.
Overlaps with 1,2,3,4,6,7

INCYTE (Talks started in May 2002)
APPLIED BIOSYSTEMS
CELERA GENOMICS
LION BIOSCIENCE
MYRIAD GENETICS
SILICO INSIGHTS
OXFORD GLYCO SCIENCES
ROSETTA INPHARMATICS


(6) University R&D Center, M/A / Professorship / Directorship

(7) Regional Center Uniqueness Cooperation / Directorship